InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Peter Unnam Park, 董事. Director active across 2 companies, notably 오름테라퓨틱. In total, 2 disclosures have been published. Activity tracked since 24 March 2026. The latest transaction was filed on 24 March 2026 (Sale). Regulator: DART (FSS). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Peter Unnam Park is a Non-Executive Director at Orum Therapeutics, a company focused on developing innovative treatments. His role involves providing strategic advice and overseeing the company's activities. His experience in the sector is valuable for shaping Orum Therapeutics' strategy.